In: Journal of Neurology, 2021, no. 268, p. 817–824
Background: Data on cancer prevalence and incidence in multiple sclerosis (MS) patients are controversial. This study is aimed at estimating cancer risk in MS patients. Methods: Nested case–control study using data collected between 01/01/1987 and 28/02/2016 from the United Kingdom Clinical Practice Research Datalink. Cancer diagnoses after first MS code (index date) was counted in 10,204 MS...
|
In: European journal of neurology, 2021, vol. 28, no. 9, p. 9
Background and purpose: Fatigue is amongst the most frequent and disabling symptoms of multiple sclerosis and a close relation between fatigue and sleep quality has been hypothesized. In this study the contribution of sleep disturbances measured by clinical and polysomnographic parameters to fatigue in multiple sclerosis was investigated. Methods: This was a prospective instrumental study...
|
In: The Cerebellum, 2015, vol. 14, no. 3, p. 364-374
|
In: Journal of Neurology, 2015, vol. 262, no. 8, p. 1909-1917
|
In: Frontiers in immunology, 2019, vol. 10, p. 711
Breakdown of the blood-brain barrier (BBB) and increased immune cell trafficking into the central nervous system (CNS) are hallmarks of the pathogenesis of multiple sclerosis (MS). Platelet endothelial cell adhesion molecule-1 (PECAM-1; CD31) is expressed on cells of the vascular compartment and regulates vascular integrity and immune cell trafficking. Involvement of PECAM-1 in MS pathogenesis...
|
In: Brain Topography, 2014, vol. 27, no. 2, p. 318-327
|
In: Acta Neuropathologica, 2014, vol. 128, no. 2, p. 231-246
|
In: Journal of Neurology, 2014, vol. 261, no. 8, p. 1606-1613
|
In: Journal of Neurology:554-560.
|
In: Journal of Molecular Neuroscience, 2008, vol. 35, no. 1, p. 91-100
|